[HTML][HTML] Immunohistochemical expression of PRAME is a marker of poor prognosis in uveal melanoma: A clinico-pathologic and immunohistochemical study on a …

G Broggi, M Failla, A Russo, A Longo, A Palicelli… - … -Research and Practice, 2023 - Elsevier
Abstract PReferentially expressed Antigen in Melanoma (PRAME) is a cancer testis antigen,
first isolated in tumor-reactive T-cell clones from a metastatic melanoma patient. It has been …

[HTML][HTML] Characterisation of the protein expression of the emerging immunotherapy targets VISTA, LAG-3 and PRAME in primary uveal melanoma: insights from a …

NJ Lamas, S Lassalle, A Martel, S Nahon-Estève… - Pathology, 2023 - Elsevier
Uveal melanoma (UM) is the most common intraocular tumour in adults, with dismal
prognosis once metastases develop, since therapeutic options for the metastatic disease are …